Cargando…
Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock
Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a do...
Autores principales: | Janson, Annika, Hällström, Cathrin, Iversen, Magnus, Finder, Mikael, Elimam, Amira, Nergårdh, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637322/ https://www.ncbi.nlm.nih.gov/pubmed/31360469 http://dx.doi.org/10.1002/ccr3.2169 |
Ejemplares similares
-
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020) -
Risperidone and Levothyroxine for Managing “Myxedema Madness”
por: Patel, Rikinkumar S, et al.
Publicado: (2020) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019) -
Mechanical Circulatory Support in Management of Cardiogenic Shock and Myxedema Coma
por: Arnautovic, Jelena Z., et al.
Publicado: (2019) -
ODP491 Levothyroxine Withdrawal Presenting as Myxedema Madness
por: Trusty, Rhonda-Kaye, et al.
Publicado: (2022)